Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18176761 | 0.87 | ALDH1A1 (0.40) | ALDH1A1 | |
| SCHEMBL9609678 | 0.79 | ALDH1A1 (0.56) | ALDH1A1LMNA | |
| SCHEMBL19977438 | 0.76 | ALDH1A1 (0.39) | ALDH1A1LMNAHTTKMT2A | |
| SCHEMBL18561743 | 0.75 | CYP2D6 (0.38) | — | |
| SCHEMBL13055293 | 0.74 | TET2 (0.39) | ALDH1A1 | |
| SCHEMBL283370 | 0.74 | — | — | |
| SCHEMBL26852304 | 0.73 | — | — | |
| SCHEMBL5365915 | 0.72 | — | — | |
| SCHEMBL28287867 | 0.71 | ALDH1A1 (0.48) | ALDH1A1LMNAHTTKMT2A | |
| SCHEMBL5752283 | 0.71 | ACLY (0.38) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230364247-A1 | NON-LINEAR MULTIBLOCK COPOLYMER-DRUG CONJUGATES FOR THE DELIVERY OF ACTIVE AGENTS | THE JOHNS HOPKINS UNIVERSITY | 2023-11-16 | — | — | US | disclosed |
| US-11660349-B2 | Non-linear multiblock copolymer-drug conjugates for the delivery of active agents | THE JOHNS HOPKINS UNIVERSITY (US) | 2023-05-30 | — | — | US | disclosed |
| US-20180028647-A1 | MODIFICATIONS OF THERAPEUTIC AGENTS FOR ENHANCED DELIVERY TO TARGET SITES | CLARIA ODIN LLC | 2018-02-01 | — | — | US | disclosed |
| US-8349783-B2 | Treatment methods using disinfecting compositions containing a polymer complex of organic acid | RECKITT BENCKISER LLC (US) | 2013-01-08 | — | — | US | disclosed |
| US-8133855-B2 | Environmentally acceptable dilutable hard surface treatment compositions | RECKITT BENCKISER LLC (US) | 2012-03-13 | — | — | US | disclosed |
| US-20120027717-A1 | TREATMENT METHODS USING DISINFECTING COMPOSITIONS CONTAINING A POLYMER COMPLEX OF ORGANIC ACID | RECKITT BENCKISER LLC. (US) | 2012-02-02 | — | — | US | disclosed |
| US-20110098210-A1 | Environmentally Acceptable Dilutable Hard Surface Treatment Compositions | Morris Corporate Center IV (US) | 2011-04-28 | — | — | US | disclosed |
| US-20110053945-A1 | SALTS OF 6-(5-CHLORO-2-PYRIDYL)-5-[(4-METHYL-1-PIPERAZINYL)CARBONYLOXY]-7-OXO-6,7-DIHY-DRO-5H-PYRROLO[3,4-B]PYRAZINE | SEPRACOR INC. (US) | 2011-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11660349-B2 | Non-linear multiblock copolymer-drug conjugates for the delivery of active agents | VEGFA, UACA, PDE6A | ALDH1A1 1084/4885LMNA 1968/4885HTT 1687/4885 |
| US-20110053945-A1 | SALTS OF 6-(5-CHLORO-2-PYRIDYL)-5-[(4-METHYL-1-PIPERAZINYL)CARBONYLOXY]-7-OXO-6,7-DIHY-DRO-5H-PYRROLO[3,4-B]PYRAZINE | MDH2, SLC25A11, MDH1 | ALDH1A1 503/4885LMNA 4874/4885HTT 3656/4885 |
| US-20230364247-A1 | NON-LINEAR MULTIBLOCK COPOLYMER-DRUG CONJUGATES FOR THE DELIVERY OF ACTIVE AGENTS | VEGFA, UACA, PDE6A | ALDH1A1 1084/4885LMNA 1968/4885HTT 1687/4885 |
| US-20180028647-A1 | MODIFICATIONS OF THERAPEUTIC AGENTS FOR ENHANCED DELIVERY TO TARGET SITES | PDK1, PC, PDK2 | ALDH1A1 1505/4885LMNA 2585/4885HTT 210/4885 |
| US-20120027717-A1 | TREATMENT METHODS USING DISINFECTING COMPOSITIONS CONTAINING A POLYMER COMPLEX OF ORGANIC ACID | POLR1C, AOC1, HAO2 | ALDH1A1 598/4885LMNA 3599/4885HTT 3252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.